BRCA1 and Hereditary breast and ovarian cancer syndrome: The purpose of this paper is to review the current knowledge about BRCA1 mutations and the correlation between these mutations and the clinical aspect in diagnosed cases of both hereditary and sporadic breast and ovarian cancer in the MECC member countries except for Israel (i.e., Cyprus, Egypt, and Jordan) and Lebanon, as well as in North Africa (Morocco, Algeria, and Tunisia).